Syntach

Syntach AB is a Swedish innovation-driven company headquartered in Lund, with close ties and extensive collaborations with various institutions at Lund University. Founded in 2012, the company aims to create an entirely new class of cardiac support devices to improve care for the rapidly growing population of heart failure patients. Since many patients requiring cardiac support also suffer from mitral regurgitation (mitral valve leakage), the company is also developing a minimally invasive device to correct this condition for use in conjunction with the cardiac support device.